SpringerLink
Log in

The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Guillemette C (2003) Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 3:136–158. doi:10.1038/sj.tpj.6500171

    Article  PubMed  CAS  Google Scholar 

  2. King CD, Rios GR, Green MD, Tephly TR (2000) UDP-glucuronosyltransferases. Curr Drug Metab 1:143–161

    Article  PubMed  CAS  Google Scholar 

  3. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677–685

    Article  PubMed  CAS  Google Scholar 

  4. Tukey RH, Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581–616. doi:10.1146/annurev.pharmtox.40.1.581

    Article  PubMed  CAS  Google Scholar 

  5. Desai AA, Innocenti F, Ratain MJ (2003) UGT pharmacogenomics: implications for cancer risk and cancer therapeutics. Pharmacogenetics 13:517–523. doi:10.1097/01.fpc.0000054116.14659.e5

    Article  PubMed  CAS  Google Scholar 

  6. Nagar S, Remmel RP (2006) Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene 25:1659–1672. doi:10.1038/sj.onc.1209375

    Article  PubMed  CAS  Google Scholar 

  7. Ohno S, Naka** S (2009) Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32–40

    Article  PubMed  CAS  Google Scholar 

  8. Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, Yokoi T (2008) Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461–1464

    Article  PubMed  CAS  Google Scholar 

  9. Izukawa T, Nakajima M, Fujiwara R, Yamanaka H, Fukami T, Takamiya M, Aoki Y, Ikushiro S, Sakaki T, Yokoi T (2009) Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab Dispos 37:1759–1768. doi:10.1124/dmd.109.027227

    Article  PubMed  CAS  Google Scholar 

  10. Turgeon D, Carrier JS, Levesque E, Hum DW, Belanger A (2001) Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778–787

    Article  PubMed  CAS  Google Scholar 

  11. Coffman BL, Rios GR, King CD, Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1–4

    PubMed  CAS  Google Scholar 

  12. Duguay Y, Baar C, Skorpen F, Guillemette C (2004) A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity. Clin Pharmacol Ther 75:223–233. doi:10.1016/j.clpt.2003.10.006

    Article  PubMed  CAS  Google Scholar 

  13. Nakamura A, Nakajima M, Higashi E, Yamanaka H, Yokoi T (2008) Genetic polymorphisms in the 5′-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation. Pharmacogenet Genomics 18:709–720. doi:10.1097/FPC.0b013e32830500c9

    Article  PubMed  CAS  Google Scholar 

  14. Sun C, Southard C, Huo D, Hernandez RD, Witonsky DB, Olopade OI, Di Rienzo A (2012) SNP discovery, expression and cis-regulatory variation in the UGT2B genes. Pharmacogenomics J 12:287–296. doi:10.1038/tpj.2011.2

    Article  PubMed  CAS  Google Scholar 

  15. Innocenti F, Liu W, Fackenthal D, Ramirez J, Chen P, Ye X, Wu X, Zhang W, Mirkov S, Das S, Cook E Jr, Ratain MJ (2008) Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Pharmacogenet Genomics 18:683–697. doi:10.1097/FPC.0b013e3283037fe4

    Article  PubMed  CAS  Google Scholar 

  16. Holthe M, Rakvag TN, Klepstad P, Idle JR, Kaasa S, Krokan HE, Skorpen F (2003) Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenomics J 3:17–26. doi:10.1038/sj.tpj.6500139

    Article  PubMed  CAS  Google Scholar 

  17. Sun C, Southard C, Witonsky DB, Olopade O, Di Rienzo A (2010) Allelic imbalance (AI) identifies novel tissue specific cis-regulatory variation for human UGT2B15. Hum Mutat 31:99–107

    Article  PubMed  CAS  Google Scholar 

  18. Kagaya H, Inoue K, Miura M, Satoh S, Saito M, Tada H, Habuchi T, Suzuki T (2007) Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Eur J Clin Pharmacol 63:279–288. doi:10.1007/s00228-006-0248-2

    Article  PubMed  CAS  Google Scholar 

  19. Holthe M, Klepstad P, Zahlsen K, Borchgrevink PC, Hagen L, Dale O, Kaasa S, Krokan HE, Skorpen F (2002) Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy. Eur J Clin Pharmacol 58:353–356. doi:10.1007/s00228-002-0490-1

    Article  PubMed  CAS  Google Scholar 

  20. Chung JY, Cho JY, Yu KS, Kim JR, Lim KS, Sohn DR, Shin SG, Jang IJ (2008) Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects. Clin Pharmacol Ther 83:595–600. doi:10.1038/sj.clpt.6100324

    Article  PubMed  CAS  Google Scholar 

  21. Thibaudeau J, Lepine J, Tojcic J, Duguay Y, Gelletier G, Plante M, Brisson J, Tetu B, Jacob S, Perusse L, Belanger A, Guillemette C (2006) Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. Cancer Res 66:125–133. doi:10.1158/0008-5472.CAN-05-2857

    Article  PubMed  CAS  Google Scholar 

  22. Gall WE, Zawada G, Mojarrabi B, Tephly TR, Green MD, Coffman BL, Mackenzie PI, Radominska-Pandya A (1999) Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol 70:101–108

    Article  PubMed  CAS  Google Scholar 

  23. Djebli N, Picard N, Rerolle JP, Meur YL, Marquet P (2007) Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on acyl-MPAG production in vitro and in adult renal transplant patients. Pharmacogenet Genomics 17:321–330

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This research was supported by National Basic Research Program of China (2013CB127500), National Institute of Health grant CA125183, and National Natural Science Foundation of China (No. 31260266).

Conflicts of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Laboratory for Conservation and Utilization of Bio-Resources, and Key Laboratory of Microbial Diversity in Southwest China, Ministry of Education, Yunnan University, Kunming, Yunnan, 650091, People’s Republic of China

    Pin-Yi Wang & Chang Sun

  2. Department of Health Studies, University of Chicago, Chicago, IL, 60637, USA

    Dezheng Huo

  3. Department of Human Genetics, University of Chicago, Chicago, IL, 60637, USA

    Chang Sun & Olufunmilayo I. Olopade

  4. Center for Clinical Cancer Genetics, Department of Medicine, University of Chicago, 5841 S Maryland Avenue, Chicago, IL, 60637, USA

    Olufunmilayo I. Olopade

Authors
  1. Pin-Yi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dezheng Huo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chang Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olufunmilayo I. Olopade
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Chang Sun or Olufunmilayo I. Olopade.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, PY., Huo, D., Sun, C. et al. The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo. Eur J Clin Pharmacol 69, 1733–1735 (2013). https://doi.org/10.1007/s00228-013-1538-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-013-1538-0

Keywords

Search

Navigation